Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $158.29 -0.45%
EPS Growth %: -5.5%
Financial Fact:
Total revenues: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -5.5%
Financial Fact:
Total revenues: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Hyperscale Data launches $300M at-the-market stock offering
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
